Clinical TrialID 8425
Supplemental Thiamine in Septic Shock: A Before-after Study
NCT05840718
Septic Shock
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8425
- Evidence Id
- 8425
- Core Evidence Id
- 8425
- Source Clinical Trial Id
- 8484
- Herb2 Clinical Trial Id
- HBCT008484
- Nct Id
- NCT05840718
- Title
- Supplemental Thiamine in Septic Shock: A Before-after Study
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Septic Shock
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: Thiamin
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 73
- Outcome Measure
- Compare lactate clearance between intervention (thiamine supplemented) and control group., Lactate clearance defined as a consistent serum lactate level below 19 mg/dL after the start of treatment for septic shock, 30 days
- Sponsor Collaborator
- Hospital Sao Domingos
- Funded By
- OTHER
- Location
- Hospital São Domingos, São Luís, Maranhão, 65060645, Brazil|Hospital Sao Domingos, Sao Luis, MA, 65060-000, Brazil
- Other Id
- 13/2023
- Start Date
- 2023-09-01
- Primary Completion Date
- 2023-11-30
- Completion Date
- 2023-12-31
- First Posted
- 2023-05-03
- Results First Posted
- Last Update Posted
- 2024-04-18
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05840718
- Title Cn
- Title En
- Supplemental Thiamine in Septic Shock: A Before-after Study
- Bilingual Status
- semi_complete